Eric Topol

American cardiologist

Eric Jeffrey Topol (born June 26, 1954) is an American cardiologist, scientist, and author. He is the founder and director of the Scripps Research Translational Institute, a professor of Molecular Medicine and Executive Vice-President at Scripps Research Institute, and a senior consultant at the Division of Cardiovascular Diseases at Scripps Clinic in La Jolla, California.

Nº Q5387640 ★★

Uncommon · People

Eric Topol

American cardiologist

Eric Jeffrey Topol (born June 26, 1954) is an American cardiologist, scientist, and author. He is the founder and director of the Scripps Research Translational Institute, a professor of Molecular Medicine and Executive Vice-President at Scripps Research Institute, and a senior consultant at the Division of Cardiovascular Diseases at Scripps Clinic in La Jolla, California.

Last price

—

Floor price

—

7-day median

—

30-day sales

0

30-day range

—

In circulation

0

Price history

Show table
Datemedian LowHighsales

Sales history

Last sale
—
30-day average
—
30-day low
—
30-day high
—
Sales 7d
0
Sales 30d
0

No sales yet.

Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.

From Wikipedia

Eric Jeffrey Topol (born June 26, 1954) is an American cardiologist, scientist, and author. He is the founder and director of the Scripps Research Translational Institute, a professor of Molecular Medicine and Executive Vice-President at Scripps Research Institute, and a senior consultant at the Division of Cardiovascular Diseases at Scripps Clinic in La Jolla, California. He has published four bestseller books on the future of medicine: The Creative Destruction of Medicine (2010); The Patient Will See You Now (2015); Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again (2019); and Super Agers: An Evidence-Based Approach to Longevity (2025). He was commissioned by the UK from 2018 to 2019 to lead planning for the National Health Service's future workforce, integrating genomics, digital medicine, and artificial intelligence. In 2016 Topol was awarded a $207 million grant from the National Institutes of Health to lead a significant part of the Precision Medicine Initiative (All of Us Research Program), a one-million-American prospective research program. This funding was renewed in 2023 for $282 million over five years. This was in addition to his role as principal investigator for the Scripps hub of the National Institutes of Health’s Clinical and Translational Science Awards (CTSA) Program, aimed at promoting innovation in medicine and future medical researchers' education and career training. Topol’s group has been supported by the CTSA since 2008, with the most recent funding of $46.8 million being awarded in 2023 for seven years.

Text: Wikipédia, CC BY-SA 4.0. · Image: Cmichel67 (CC BY-SA 4.0) ·

Related cards

View card

Confirmation